Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma. - Barrios, Carlos H.; Hernandez-Barajas, David; Brown, Michael P.; Lee, Se-Hoon; Fein, Luis; Liu, Jin-Hwang; Hariharan, Subramanian; Martell, Bridget A.; Yuan, Jinyu; Bello, Akintunde; Wang, Zhixiao; Mundayat, Rajiv; et al. (Cancer (0008543X), 2012)